Truveta Enhances Medical Device Data Capabilities

New updates have been reported about Truveta (PC:TRVTA)

Truveta has announced a significant enhancement to its real-world device data capabilities, providing device manufacturers and regulators with an unprecedented, comprehensive view of medical device performance. By integrating unique device identifier (UDI) data with minute-level admission–discharge–transfer (ADT) and chargemaster data, Truveta offers a detailed perspective on device usage, facilitating accelerated regulatory submissions, health economics and outcomes research (HEOR), and safety monitoring. Truveta stands as a leading source of real-world data, leveraging daily updated, representative electronic health record (EHR) data from U.S. health systems. This integration with closed claims data allows for a complete, longitudinal view of patient care, enhancing research precision on device usage, safety, and outcomes. Unlike data sources focused solely on billing, Truveta captures the entire patient journey, from pre-diagnosis to recovery, using structured EHR data, clinical notes, images, claims, and mortality data. Truveta’s dataset includes device records and clinical notes for over 10 million patients, offering unmatched precision with UDI-level detail and procedural context. Michael Simonov, MD, Senior Vice President of Product at Truveta, emphasized the unique integration of device identity, procedural detail, outcomes, and cost in a single, research-ready dataset, trusted by regulators. This advancement positions Truveta as a leader in real-world data for cardiovascular research, enabling detailed evaluations of device safety and efficacy. George Miller, Director of Clinical Affairs at Medcomp, highlighted the granularity of Truveta Data, which allows for insights into individual design variations previously unattainable. Truveta continues to transform medical science with its comprehensive data and predictive AI, driving breakthrough discoveries and real-time insights.